These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 29926655

  • 1. [Effects of hydrogen sulfide (H2S) on cardiac hypertrophy and miRNA-133a-mediated Ca2+/calcineurin/NFATc4 signal pathway in rats].
    Wu Y, Guo YY, Zhang YY, Zhang Y.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan 08; 34(1):29-34. PubMed ID: 29926655
    [Abstract] [Full Text] [Related]

  • 2. [MicroRNA-133a attenuates isoproterenol-induced neonatal rat cardiomyocyte hypertrophy by downregulating L-type calcium channel α1C subunit gene expression].
    Wu Y, Wang YQ, Wang BX.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun 08; 41(6):507-13. PubMed ID: 24113045
    [Abstract] [Full Text] [Related]

  • 3. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
    Sugiyama A, Okada M, Yamawaki H.
    Eur J Pharmacol; 2020 Mar 15; 871():172849. PubMed ID: 31843516
    [Abstract] [Full Text] [Related]

  • 4. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
    Tan X, Li J, Wang X, Chen N, Cai B, Wang G, Shan H, Dong D, Liu Y, Li X, Yang F, Li X, Zhang P, Li X, Yang B, Lu Y.
    Int J Biol Sci; 2011 Apr 07; 7(3):383-9. PubMed ID: 21494433
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway.
    Liu XP, Gao H, Huang XY, Chen YF, Feng XJ, He YH, Li ZM, Liu PQ.
    Transl Res; 2015 Nov 07; 166(5):459-473.e3. PubMed ID: 26118953
    [Abstract] [Full Text] [Related]

  • 6. Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells.
    Asadi F, Razmi A, Dehpour AR, Shafiei M.
    J Pharm Pharmacol; 2016 Apr 07; 68(4):485-93. PubMed ID: 26945895
    [Abstract] [Full Text] [Related]

  • 7. NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression.
    Li Q, Lin X, Yang X, Chang J.
    Am J Physiol Heart Circ Physiol; 2010 May 07; 298(5):H1340-7. PubMed ID: 20173049
    [Abstract] [Full Text] [Related]

  • 8. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z, Wang X, Zhang L, Zhou H, Wei L, Dong X.
    Cardiovasc Ther; 2016 Feb 07; 34(1):21-9. PubMed ID: 26506219
    [Abstract] [Full Text] [Related]

  • 9. NFAT regulation of cystathionine γ-lyase expression in endothelial cells is impaired in rats exposed to intermittent hypoxia.
    Gonzalez Bosc LV, Osmond JM, Giermakowska WK, Pace CE, Riggs JL, Jackson-Weaver O, Kanagy NL.
    Am J Physiol Heart Circ Physiol; 2017 Apr 01; 312(4):H791-H799. PubMed ID: 28130342
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
    Zhang X, Xia J, Qian D, Wang Y, Lin Y, Huang X, Tan J.
    Cardiology; 2014 Apr 01; 129(3):153-62. PubMed ID: 25277512
    [Abstract] [Full Text] [Related]

  • 12. [The effect of relgulation of PPAR-α on cardiac hypertrophy and the relationship between the effect of PPAR-α with PI3K/Akt/mTOR pathway].
    Wu Y, Wang BX, Guo YY, Wang YQ.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May 01; 31(3):284-8. PubMed ID: 26387199
    [Abstract] [Full Text] [Related]

  • 13. KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.
    Liou SF, Hsu JH, Chen YT, Chen IJ, Yeh JL.
    Molecules; 2015 Jun 05; 20(6):10435-49. PubMed ID: 26056815
    [Abstract] [Full Text] [Related]

  • 14. Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
    Chen Y, Yuan J, Jiang G, Zhu J, Zou Y, Lv Q.
    Mol Med Rep; 2017 Oct 05; 16(4):4545-4552. PubMed ID: 28849081
    [Abstract] [Full Text] [Related]

  • 15. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W, Deng J, Ding W, Wang G, Shen Y, Zheng J, Zhang X, Luo Y, Lv C, Wang Y, Chen L, Yan D, Boudreau RL, Song LS, Liu J.
    Circ Heart Fail; 2017 Jun 05; 10(6):. PubMed ID: 28611128
    [Abstract] [Full Text] [Related]

  • 16. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H, Jia G, Liu X, Liu Z, Wang H.
    Environ Toxicol Pharmacol; 2014 Jul 05; 38(1):263-71. PubMed ID: 24975447
    [Abstract] [Full Text] [Related]

  • 17. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H, Gao S, Ye J, Feng X, Cai Y, Liu Z, Lu J, Li Q, Huang X, Chen S, Liu P.
    Mol Cell Endocrinol; 2014 Feb 15; 382(2):998-1006. PubMed ID: 24291639
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
    Cai B, Tan X, Zhang Y, Li X, Wang X, Zhu J, Wang Y, Yang F, Wang B, Liu Y, Xu C, Pan Z, Wang N, Yang B, Lu Y.
    Stem Cells Transl Med; 2015 Dec 15; 4(12):1425-35. PubMed ID: 26586774
    [Abstract] [Full Text] [Related]

  • 20. NAKα2 inhibits fibrosis formation and protects against cardiomyocyte hypertrophy by suppressing hypertrophy associated molecules and activating LTCC/NCX signaling pathway.
    Song SS, Tang G, Tang LX, Si LY, Xiong W.
    Eur Rev Med Pharmacol Sci; 2019 Apr 15; 23(7):3021-3033. PubMed ID: 31002153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.